Direct effects of somatostatin analog octreotide on insulin-like growth factor-I in the arterial wall

Laboratory Investigation

Volumn 76, Issue 3, 1997, Pages 329-338

  Yumi, Koshi ^a   Fagin, James A ^c   Yamashita, Makoto ^a   Fishbein, Michael C ^a   Shah, Prediman K ^a   Kaul, Sanjay ^a   Niu, Wen ^c   Nilsson, Jan ^a,b   Cercek, Bojan ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; GLUCAGON; GROWTH HORMONE; MESSENGER RNA; OCTREOTIDE; PLATELET DERIVED GROWTH FACTOR A; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOMATOSTATIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; CONTROLLED STUDY; DRUG EFFECT; FEMORAL ARTERY; GENE EXPRESSION; GENE INDUCTION; GLUCAGON BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANGIOPLASTY, BALLOON; ANIMALS; FEMORAL ARTERY; GLUCAGON; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE, SMOOTH, VASCULAR; OCTREOTIDE; PROLIFERATING CELL NUCLEAR ANTIGEN; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC;

EID: 0030940909     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. 3H Thymidine incorporation by angiopeptin in the aorta of rabbits after balloon angioplasty. Transplant Proc 21:3695-3696.
2. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, and Pless J (1982). SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:1133-1140.
3. Bradford MM (1976). A rapid and sensitive method for he quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Bruno JF, Jun X, Song J, and Berelowitz M (1993). Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133:2561-2567.
5. Cercek B, Fishbein MC, Forrester JS, Helfant RH, and Fagin JA (1990). Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res 66:1755-1760.
6. Clemmons DR (1985). Exposure to platelet-derived growth factor modulates the porcine aortic smooth muscle cell response to somatomedin-C. Endocrinology 117:77-83.
7. Davis LG, Dibner MD, and Battey JF (1986). Northern hybridization. In: Basic methods in molecular biology. New York: Elsevier Science Publishing, 133-135.
8. Ezzat S, Ren S-G, Braunstein DG, and Melmed S (1992). Octreotide stimulates insulin-like growth factor-binding protein-I: A potential pituitary-independent mechanism for drug action. J Clin Endocrinol Metab 75:1459-1463.
9. Feng L, Xia Y, Tang WW, and Wilson CB (1993). Cloning a novel form of rat PDGF-A chain with a unique 5′ UT: Regulation during development and glomerulonephritis. Biochem Biophys Res Commun 194:1453-1459.
10. Fishman JA, Ryan GB, and Karnovsky MJ (1975). Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest 32:339-351.
11. Flyvberg A, Frystyk J, Thorlacius-Ussing O, and Orskov H (1989). Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 32:261-265.
12. Foegh ML, Khirabadi BS, Chambers E, Amamoo D, and Ramwell PW (1989). Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide. Atherosclerosis 78:229-236.
13. Fredstorp L, Werner S, Bang P, and Hall K (1994). Inverse correlation between insulin-like growth factor binding protein-1 and insulin in patients with acromegaly during treatment with the somatostatin analogue octreotide. Clin Endocrinol 41:495-501.
14. Giannella-Neto D, Kamyar A, Sharifi B, Pirola CJ, Kupfer J, Rosenfeld RG, Forrester JS, and Fagin JA (1992). Platelet-derived growth factor isoforms decrease insulin-like growth factor I gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4. Circ Res 71:646-656.
15. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, and Pepine CJ (1994). Localization of insulin-like growth factor-I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. Circulation 89:1511-1517.
16. Jones JI and Clemmons DR (1995). Insulin-like growth factors and their binding proteins: Biological actions. Endocrine Rev 16:3-34.
17. Kamyar A, Pirola CJ, Wang H-M, Sharifi B, Mohan S, Forrester JS, and Fagin JA (1995). Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells. Circ Res 74:576-585.
18. Khorsandi MJ, Fagin JA, Forrester JS, and Cercek B (1992a). Effects of hypophysectomy on vascular insulin-like growth factor-I gene expression after balloon denudation in rats. Atherosclerosis 93:115-122.
19. Khorsandi MJ, Fagin JA, Giannella-Neto D, Forrester JS, and Cercek B (1992b). Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation. J Clin Invest 90:1926-1931.
20. Kiefer MC, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz FR, Green K, Barr PJ, and Zapf J (1992). Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J Biol Chem 267:12692-12699.
21. Kokudo N, Kothary PC, Eckhauser FE, and Nakamura T (1992). Inhibition of DNA synthesis by somatostatin in rat hepatocytes stimulated by hepatocyte growth factor or epidermal growth factor. Am J Surg 163:169-173.
22. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
23. Lowe WL, Meyer T, Karpen CW, and Lorentzen LR (1992). Regulation of insulin-like growth factor I production in rat C6 glioma cells: Possible role as an autocrine/paracrine growth factor. Endocrinology 130:2683-2691.
24. Lundergan C, Foegh ML, Vargas R, Eufemio M, Bormes GW, Kot PA, and Ramwell PW (1989). Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034. Atherosclerosis 80:49-55.
25. Luo J and Murphy U (1989). Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I messenger ribonucleic acid in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Endocrinology 125:165-171.
26. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, and Schwartz SM (1990). PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 111: 2149-2158.
27. Marbach P, Briner U, Lemaire M, Schweitzer A, and Terasaki T (1992). From somatostatin to sandostatin: Pharmacodynamics and pharmacokinetics. Metabolism 41:7-10.
28. Murphy LJ, Seneviratne C, Ballejo G, Croze F, and Kennedy TG (1990). Identification and characterization of rat decidual insulin-like growth factor-binding protein complementary DNA. Mol Endocrinol 4:329-365.
29. Plewe G, Beyer J, Krause U, Neufeld M, and Delpozo E (1984). Long-acting and selective suppression of growth factor hormone secretion by somatostatin analogue SMS 201-995 in acromegaly. Lancet 2:782-784.
30. Ren S-G, Ezzat S, Melmed S, and Braunstein GD (1992). Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells. Endocrinology 131:2479-2481.
31. Sakamoto C, Matozaki T, Nagao M, and Baba S (1987). Coupling of guanine nucleotide inhibitory protein to somatostatin receptors on pancreatic acinar membranes. Am J Physiol 253:G308-G313.
32. Sassolas G and Melmed S (1992). Basic somatostatin research. Metabolism 41:11-16.
33. Serri O, Brazeau P, Kachra Z, and Posner B (1992). Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: Evidence for a direct and indirect mechanism of action. Endocrinology 130:1816-1821.
34. Shimasaki S, Uchiyama F, Shimonaka M, and Ling N (1990). Molecular cloning of the cDNAs encoding a novel insulin-like growth factor binding protein from rat and human. Mol Endocrinol 4:1451-1458.
35. Stiles CD, Capone GT, Sher CD, Antoniades HN, Van Wyk JJ, and Pledger WJ (1977). Dual control of cell growth by somatomedins and platelet derived growth factor. Proc Natl Acad Sci USA 76:1279-1283.
36. Takahashi K, Daughaday WH, and Kipnis DM (1971). Regulation of immunoreactive growth hormone secretion in male rats. Endocrinology 88:909-916.
37. Tauber JP, Babin T, Tauber MT, Vigoni F, Bonafe A, Ducasse M, Harris AG, and Bayard F (1989). Longterm effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly. J Clin Endocrinol Metab 68:917-924.
38. Tiell ML, Stemerman MB, and Spaet TH (1976). The influence of pituitary on arterial intimai proliferation in the rat. Circ Res 42:644-649.
39. Tsuzaki S and Moses AC (1990). Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-I in FRTL5 cells. Endocrinology 126:3131-3138.
40. Viguerie N, Tahiri-Jouti N, Ayral AM, Cambillau C, Scemama JL, Bastie MJ, Knuhtsen S, Esteve JP, Pradayrol L, Susini C, and Vaysse N (1989). Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism. Endocrinology 124:1017-1025.
41. Zeymer U, Fishbein MC, Forrester JS, and Cercek B (1992). Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Am J Pathol 141:685-690.